Nyika haigone kuisa pangozi vakuru nekuzorora COVID mutemo
By ZHANG ZHIHAO | CHINA DAILY | Updated: 2022-05-16 07:39
Mumwe mugari wechikuru anotariswa BP asati apihwa pfuti yakeMushonga unobetsera kudzivirira covid-19kumba muDongcheng mudunhu reBeijing, Chivabvu 10, 2022. [Mufananidzo/Xinhua]
Yepamusoro booster kupfurwa kuvharwa kwevakweguru, kutonga kuri nani kwenyaya nyowani uye zviwanikwa zvekurapa, kunyatsoita uye kuwanikwa kuyedzwa, uye kurapwa kumba kweCCIDID-19 ndizvo zvimwe zvakakosha zvinodiwa kuti China igadzirise mutemo wayo uripo kudzora COVID, nyanzvi yepamusoro yechirwere chinotapukira. akadaro.
Pasina zvimiro izvi, kubvumidzwa kwakasimba kunoramba kuri kwakanyatso kurongeka uye kurongeka kweChina sezvo nyika isingakwanise kuisa hupenyu hwevakuru vayo panjodzi nekuzorora matanho ekurwisa denda nguva isati yakwana, akadaro Wang Guiqiang, mukuru wedhipatimendi rezvirwere zvinotapukira kuPeking University First Hospital. .
Nyika yeChinese yakataura mazana maviri nemakumi maviri nenhanhatu-yakatemerwa munharaunda-yakatemerwa nyaya dzeCCIDID-19 nemugovera, idzo 166 dzaive muShanghai uye makumi matatu nevatatu vaive muBeijing, sekureva kweNational Health Commission nemusi weSvondo.
Mumusangano weruzhinji nemusi weMugovera, Wang, ari zvakare nhengo yechikwata chenyika nyanzvi pakurapa nyaya dzeCCIDID-19, akati kubuda kweCCIDID-19 muHong Kong neShanghai kwakaratidza kuti musiyano weOmicron unogona kutyisidzira zvakanyanya. vakwegura, kunyanya avo vasina kubaiwa uye vane hutano huri pasi pemamiriro ezvinhu.
"Kana China ichida kuvhurazve, chinodiwa cheNo 1 ndechekudzikisa huwandu hwevanhu vafa neCCIDID-19 kubuda, uye nzira yakanakisa yekuzviita nekudzivirira," akadaro.
Hofisi yeHong Kong Special Administrative Region yehutano hweveruzhinji yakaratidza kuti kubva Mugovera, huwandu hwekufa kwedenda reOmicron hwaive 0.77 muzana, asi huwandu hwakakwira kusvika pa2.26 muzana yevasina kubayiwa kana avo vasina kupedzisa majekiseni avo.
Vanhu vanosvika 9,147 vafa mukubuda kweguta kubva Mugovera, ruzhinji rwevanhu vakuru vane makore makumi matanhatu zvichikwira. Kune avo vari pamusoro pemakore makumi masere, huwandu hwekufa hwaive 13.39 muzana kana vasina kugamuchira kana kupedza majekiseni avo ekudzivirira.
Kubva nemusi weChina, vakuru vanopfuura mamirioni mazana maviri nemakumi maviri nevaviri vari pamusoro pemakore makumi matanhatu pazera reChina vakabaiwa, avo mamirioni mazana maviri nemakumi maviri nenhanhatu vakapedza kosi yakazara inoculation uye vangangosvika mamirioni zana nemakumi matanhatu nevakuru vakagamuchira pfuti, akadaro National Health Commission. Nyika yeChinese yaive nevanhu vanosvika mamirioni mazana maviri nemakumi matanhatu muzera iri kubva munaNovember 2020.
Kudzivirira kwakakosha
"Kuwedzera vaccine uye booster pfuti yekuvhara kune vakweguru, kunyanya avo vanopfuura makore makumi masere, kwakakosha mukuvadzivirira kubva kuhurwere hwakakomba nerufu," akadaro Wang.
China yave kutogadzira mishonga yekudzivirira yakagadzirirwa zvakanangana neiyo inofambiswa zvakanyanya Omicron musiyano. Kutanga mwedzi uno, China National Biotech Group, inotsigira Sinopharm, yakatanga miedzo yekiriniki yekudzivirira kweOmicron muHangzhou, mudunhu reZhejiang.
Sezvo dziviriro yekudzivirira kubva kukoronavirus ichigona kupera nekufamba kwenguva, zvinogoneka uye zvakakosha kuti vanhu, kusanganisira avo vakambopfurwa, vawedzere kusadzivirirwa kwavo neOmicron vaccine kana yangobuda, Wang akawedzera.
Kunze kwekudzivirira, Wang akati zvakakosha kuve neyakagadziridzwa COVID-19 kubuda mhinduro nzira yekuchengetedza hutano hwenyika.
Semuyenzaniso, panofanirwa kuve nemitemo yakajeka yekuti ndiani uye sei vanhu vanofanirwa kugariswa pamba kuitira kuti vashandi venharaunda vagone kubata nemazvo uye kushandira vanhu vakagariswa, uye kuti zvipatara zvisakurirwe nekuwanda kwevarwere vane hutachiona.
"Zvakakosha kuti zvipatara zvipe akakosha mabasa ekurapa kune vamwe varwere panguva yeCCIDID-19. Kana kuvhiyiwa uku kukavhiringwa neboka revarwere vatsva, zvinogona kukonzera kukuvara kwakananga, izvo zvisingatenderwe,” akadaro.
Vashandi vomunharaunda vanofanirawo kuchengetedza mamiriro evakwegura uye avo vane zvinodiwa zvekurapwa vari voga, saka vashandi vezvokurapa vanogona kukurumidza kupa rubatsiro rwekurapa kana zvichidiwa, akawedzera.
Pamusoro pezvo, veruzhinji vanozoda zvinokwanisika uye zvinowaniswa mishonga yeantiviral, akadaro Wang. Ikozvino monoclonal antibody kurapwa inoda jekiseni remutsinga munzvimbo yechipatara, uye Pfizer's COVID oral pill Paxlovid ine mutengo wakakura we2,300 yuan ($338.7).
“Ndinovimba kuti mishonga yedu yakawanda, pamwe nemishonga yechivanhu yekuChina, inogona kuita basa guru mukurwisa denda iri,” vakadaro. "Kana tikakwanisa kurapwa zvine simba uye zvisingadhuri, saka tichava nechivimbo chekuvhurazve."
Zvinodiwa zvakakosha
Zvichakadaro, kuvandudza huroyi hwekukurumidza antigen yekuzviongorora kits uye kuwedzera nucleic acid bvunzo kuwana uye kugona padanho renharaunda zvakare zvakakosha zvinodikanwa zvekuvhurazve, akadaro Wang.
"Kazhinji kutaura, ino haisi nguva yekuti China ivhurwe zvakare. Nekuda kweizvozvo, tinofanirwa kusimudzira hurongwa hwekubvisa uye kuchengetedza vakuru nenyaya dzehutano, "akadaro.
Lei Zhenglong, mutevedzeri wemukuru weNational Health Commission's Bureau of Disease Prevention and Control, akadzokorora neChishanu kuti mushure mekurwisa denda reCCIDID-19 kweanopfuura makore maviri, hurongwa hwekubvisa huchapa hwakaratidza kushanda mukuchengetedza hutano hweveruzhinji, uye iyo yakanakisa sarudzo yeChina yakapihwa mamiriro azvino.
Nguva yekutumira: May-16-2022